predictions?, page-26

First 26 Last

Share
Profile

Follow
Orioles

327 Posts.

7

30/03/18

01:43

Post #: 32136121
Share
H

Originally posted by Orioles ↑

The drug is not meant to reduce liver fat.  Nothing about its MoA would suggest that it does.  This shouldn't have been coded as the primary endpoint and isn't in the remaining two trials.  Allergan bought Tobira for massive share price premium after it missed it's primary endpoint but showed positive effects on key secondary endpoints.

The key take away is the statistically significant effect on the multitude of other key endpoints.  Because most diseases have more than one consequence, many trials are designed to examine the effect of a drug on more than one endpoint. In some cases, efficacy cannot be adequately  established on the basis of a single endpoint. In other cases, an effect on any of several  endpoints could be sufficient to support approval of a marketing application.

Results demonstrate excellent safety and tolerability

Statistically significant reduction in serum endotoxin/ Lipopolysaccharide (LPS) levels compared to placebo

Statistically significant reduction in mean serum ALT in patients with elevated pre-treatment ALT

Statistically significant Reduction of additional serum NASH biomarkers associated with liver damage – AST and CK-18

Expand

Here.  For your pleasure reading:

https://www.marketwatch.com/story/t...fter-trial-misses-primary-endpoint-2016-07-25

Allergan then quickly bought for Tobira for 1,800% price premium.
IMC Price at posting: 37.5¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

Money and Investing: Australia’s Real Inflation Rate Explained

TGN

Tungsten has soared +700% YTD, the US is curbing its exports, and this ASX stock is targeting production in Q1CY27

Monday’s HotCopper trends: DXN, Right Resources, North Stawell Minerals and other daily topics

ASX Today: Miners lift market as gold hits three month high

ALD

Ampol profit surges as Middle East war sends refining earnings soaring

First 26 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.


Last 3.4¢		Change 0.000(0.00%)		Mkt cap ! $11.10M

Open	High	Low	Volume
0.0¢	0.0¢	0.0¢	0

Last trade - 10.00am 24/08/2026 (20 minute delay)

IMC (ASX) Chart

Day chart unavailable

predictions?, page-26

Money and Investing: Australia’s Real Inflation Rate Explained

Tungsten has soared +700% YTD, the US is curbing its exports, and this ASX stock is targeting production in Q1CY27

Monday’s HotCopper trends: DXN, Right Resources, North Stawell Minerals and other daily topics

ASX Today: Miners lift market as gold hits three month high

Ampol profit surges as Middle East war sends refining earnings soaring

Featured News

Featured News

predictions?, page-26

Top Stories

Money and Investing: Australia’s Real Inflation Rate Explained

Tungsten has soared +700% YTD, the US is curbing its exports, and this ASX stock is targeting production in Q1CY27

Monday’s HotCopper trends: DXN, Right Resources, North Stawell Minerals and other daily topics

ASX Today: Miners lift market as gold hits three month high

Ampol profit surges as Middle East war sends refining earnings soaring

Featured News

Featured News